Skip to content

Lidocaine 5% Patch Supplementation to Intra-articular Bupivacaine Dexmedetomidine After Arthroscopic Knee Surgery

Effect of Lidocaine 5% Patch Supplementation to Intra-articular Bupivacaine Dexmedetomidine After Arthroscopic Knee Surgery Under General Anesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04322760
Enrollment
40
Registered
2020-03-26
Start date
2016-12-01
Completion date
2017-12-01
Last updated
2020-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroscopic Knee Surgery, Dexmedetomidine, Intra-articular, Lidocaine 5% Patch

Brief summary

Surgery of the knee is a very common procedure which can be very painful and sufficient postoperative pain treatment is often problematic. The aim of this work was to study the effects of supplementation of intra-articular bupivacaine dexmedetomidine with lidocaine 5% patch after arthroscopic knee surgery under general anesthesia and its role in improving quality of anesthesia.

Interventions

DRUGLidocaine 5% patch with Dexmedetomidine Bupivacaine

10 ml 0.5 % Bupivacaine and 1µg/kg Dexmedetomidine diluted in 10 ml saline was injected intra-articularly through one of the arthroscopic ports after the end of the surgery under complete aseptic technique and a patch of lidocaine 5% was applied to the skin between the arthroscopic ports

10 ml 0.5 % Bupivacaine and 1µg/kg Dexmedetomidine diluted in 10 ml saline was injected intra-articularly through one of the arthroscopic ports after the end of the surgery under complete aseptic technique without a patch of lidocaine 5%

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Patients were allocated into 2 groups, 20 patients in each received 10 ml 0.5 % bupivacaine and 1µg/kg dexmedetomidine diluted in 10 ml saline injected intra-articularly; group A: no patch, group B: a patch of lidocaine 5% was applied to the skin.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients * ASA I & II * Aged between 18 to 60 years * Weight between 60 to 100 kg * Scheduled for elective arthroscopic knee surgery

Exclusion criteria

* patient refusal. * history of cardiac disease. * impaired renal or hepatic function. * hypertension treated with α methyldopa, clonidine, or beta-adrenergic blockers. * if they have used opioid analgesics within the previous 24 hr. * previous sensitivity to local anesthetics.

Design outcomes

Primary

MeasureTime frameDescription
The total dose of postoperative pethidine consumption24 hoursThe total dose of postoperative pethidine consumption; Pethidine 20 mg was given as rescue analgesia if pain visual analogue visual analogue scale (VAS) ≥4.

Secondary

MeasureTime frameDescription
First postoperative analgesia request time24 hoursFirst postoperative analgesia (Pethidine 20 mg) request time
Pain intensity24 hoursVisual analogue scale (VAS) was recorded immediately postoperative and at 30 min, 1, 2, 4, 6, 12 and 24 hours postoperatively. The score ranges from 0 to 10; higher means worse pain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026